• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.26% Nasdaq Up0.23%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    474.17 Up 3.01(0.64%) May 4, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 802,329   725,788   665,700   625,740  
    Cost of Revenue59,474  55,593  46,379  43,572  
    Gross Profit 742,855   670,195   619,321   582,168  
    Operating Expenses
    Research Development351,745  337,728  294,501  287,379  
    Selling General and Administrative143,743  149,748  102,414  108,850  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 247,367   182,719   222,406   185,939  
    Income from Continuing Operations
    Total Other Income/Expenses Net(19,730)2,591  (9,110)937  
    Earnings Before Interest And Taxes227,637  185,310  213,296  186,876  
    Interest Expense6,350  9,232  10,177  11,613  
    Income Before Tax221,287  176,078  203,119  175,263  
    Income Tax Expense111,111  96,358  110,384  109,820  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops87,494  79,720  81,948  65,443  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 110,176   79,720   92,735   65,443  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 110,176   79,720   92,735   65,443  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.